Mibefradil, a selective calcium T-channel blocker, in stroke-prone spontaneously hypertensive rats

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 5, 1996, Pages 686-694

  Vacher, Elisabeth ^a   Richer, Christine ^a   Fornes, Paul ^a   Clozel, Jean Paul ^b   Giudicelli, Jean François ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Calcium antagonists; Histological structural alterations; Mibefradil; Middle cerebral artery's reactivity; Mortality; Stroke; Stroke prone spontaneously hypertensive rats

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; MIBEFRADIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIURESIS; DRUG EFFICACY; HYPERTENSION; MALE; MIDDLE CEREBRAL ARTERY; MORPHOMETRICS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; SURVIVAL;

ANIMALS; BENZIMIDAZOLES; BLOOD PRESSURE; BODY WEIGHT; CALCIUM CHANNEL BLOCKERS; CEREBRAL ARTERIES; CEREBROVASCULAR DISORDERS; HEART RATE; HYPERTENSION; MALE; MIBEFRADIL; RATS; RATS, INBRED SHR; TETRAHYDRONAPHTHALENES;

EID: 0029914896     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199605000-00011     Document Type: Article

References (40)

1. Philips SJ, Whisnant JP. Hypertension and stroke. In: Laragh H, Brenner BM, eds. Hypertension: pathology, diagnosis and management. New York: Raven Press, 1990:417-31.
2. Okamoto K, Yamori Y, Nagaoka A. Establishment of the stroke-prone spontaneously hypertensive rat (SHR). Circ Res 1974;34-35(suppl I):I143-53.
3. Tagami M, Nara Y, Kubota A, et al. Ultrastructural characteristics of occluded perforating arteries in stroke-prone spontaneously hypertensive rats. Stroke 1987;18:733-40.
4. Ogata J, Fujishima M, Tamaki K, Nakatomi Y, Ishitsuka T, Omae T. Stroke-prone spontaneously hypertensive rats as an experimental model of malignant hypertension. I. A light- and electron-microscopic study of the brain. Acta Neuropathol 1980;51:179-84.
5. Baumbach GL, Dobrin PB, Hart MN, Heistad DD. Mechanics of cerebral arterioles in hypertensive rats. Circ Res 1988;62:56-64.
6. Smeda JS. Cerebral vascular changes associated with hemorrhagic stroke in hypertension. Can J Physiol Pharmacol 1992;70:552-64.
7. Mayhan WG, Faraci FM. Cerebral vasconstrictor responses to serotonin during chronic hypertension. Hypertension 1990;15:872-6.
8. Yamori Y, Horie R, Tanase H, Fujiwara K, Nara Y, Lovenberg W. Possible role of nutritional factors in the incidence of cerebral lesions in stroke-prone spontaneously hypertensive rats. Hypertension 1984;6:49-53.
9. Stier CT, Benter IF, Ahmad S, et al. Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats. Hypertension 1989;13:115-21.
10. Stier CT, Chander PN, Gutstein WH, Levine S, Itskovitz HD. Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect. Am J Hypertens 1991;4:680-7.
11. Vacher E, Fornes P, Domergue V, Richer C, Bruneval P, Giudicelli JF. Quinapril prevents stroke both during and after the treatment period in stroke-prone spontaneously hypertensive rats. Am J Hypertens 1993;6:951-9.
12. Richer C, Fornes P, Vacher E, Bruneval P, Giudicelli JF. Trandolapril's protective effects in stroke-prone spontaneously hypertensive rats persist after treatment withdrawal. Am J Cardiol 1994; 73:26C-35C.
13. Camargo MJF, Von Lutterotti N, Pecker MS, James GD, Timmermans PBMWM, Laragh JH, DuP 753 increases survival in spontaneously hypertensive stroke-prone rats fed a high sodium diet. Am J Hypertens 1991;4:S341-5.
14. Fornes P, Richer C, Vacher E, Bruneval P, Giudicelli JF. Losartan's protective effects in stroke-prone spontaneously hypertensive rats persist durably after treatment withdrawal. J Cardiovasc Pharmacol 1993;22:305-13.
15. Kazda S, Garthoff B, Hirth C, Preis W, Stasch JP. Parathyroidectomy mimics the protective effect of the calcium antagonist nimodipine in salt-loaded stroke-prone spontaneously hypertensive rats. J Hypertens 1986;4(suppl 3):S483-5.
16. Gries J, Kretzschmar R, Neumann BW. Development of hypertension and lifespan in stroke-prone spontaneously hypertensive rats during oral long-term treatment with various antihypertensive drugs. J Cardiovasc Pharmacol 1989:13(suppl 4):S79-82.
17. Nagaoka A, Imamoto T, Sekiguchi M, Hirai K, Nagai Y, Shino A. Manidipine, a new calcium antagonist, prevents the development and progression of cerebrovascular lesions in stroke-prone spontaneously hypertensive rats. In: Sassard J, ed. Genetic hypertension. London: Colloque INSERM/John Libbey Eurotext 1992:595-7.
18. Nayler WG. Calcium, calcium antagonism, atherosclerosis, and ischemia. J Cardiovasc Pharmacol 1992;19(suppl 2):S17-21.
19. Takakura S, Furuichi Y, Yamamoto T, Ogawa T, Satoh H, Mori J. Effect of nilvadipine on the development of neurological deficits in stroke-prone spontaneously hypertensive rats. Stroke 1994;25: 677-83.
20. Shinyama H, Nagai H, Kawamura T, et al. Protective effects of AE0047, a novel calcium antagonist, on incidence of stroke and hemodynamic disturbances in stroke-prone spontaneously hypertensive rats. J Pharmacol Exp Ther 1995;272:911-9.
21. Clozel JP, Banken L, Osterrieder W. Effects of Ro 40-5967, a novel calcium antagonist, on myocardial function during ischemia induced by lowering coronary perfusion pressure in dogs: comparison with verapamil. J Cardiovasc Pharmacol 1989;14:713-21.
22. 2+ channels by RO 40-5967. Circ Res 1994;75:144-8.
23. Schmitt R, Clozel JP, Iberg N, Bühler FR. Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel. Arterioscler Thromh Vasc Biol 1995;15:1161-5.
24. Hefti F, Clozel JP, Osterrieder W. Antihypertensive properties of the novel calcium antagonist (1S,2S)-2-[2-[[3-(2-benzimidazolyl)propyl]methylamino]ethyl]-6-fluoro-1,2,3,4- tetrahydro-1-isopropyl-2-naphthyl methoxyacetate dihydrochloride in rat models of hypertension. Comparison with verapamil. Arzneimittelforschung Drug Res 1990;40:417-21.
25. Bunag RD, Butterfield J. Tail-cuff blood pressure measurement without external preheating in awake rats. Hypertension 1982;4: 898-903.
26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193: 265-75.
27. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977;41:19-26.
28. Mulvany MJ, Hansen PK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media and an increased number of smooth muscle cell layers. Circ Res 1978;43:854-64.
29. Mantel N. Chi-square tests with one degree of freedom: extension of the Mantel-Haenszel procedure. J Am Stat Assoc 1963;58:690-700.
30. Ludbrook J. Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc Res 1994;28:303-11.
31. Clozel JP, Osterrieder W, Kleinbloesem CH, et al. Ro 40-5967: a new nondihydropyridine calcium antagonist. Cardiovasc Drug Rev 1991;9:4-17.
32. Véniant M, Heudes D, Clozel JP, Bruneval P, Ménard J. Calcium blockade versus ACE inhibition in clipped and undipped kidneys of 2K-1C rats. Kidney Int 1994;46:421-9.
33. Korner PI, Bobik A, Angus JA. Are cardiac and vascular amplifiers both necessary for the development of hypertension? Kidney Int 1992;41(suppl 37):S38-44.
34. Yamori Y, Horie R. Developmental course of hypertension and regional cerebral blood flow in stroke-prone spontaneously hypertensive rats. Stroke 1977;8:456-61.
35. Matsunaga K, Masui M, Ueda M. Pharmacological studies on a new dihydrothienopyridine calcium antagonist S-312-d: therapeutic effects of S-312-d on cerebral metabolic impairment in stroke-prone spontaneously hypertensive rats. Drug Dev Res 1994;33: 10-9.
36. Mayhan WG, Faraci FM, Heistad DD. Impairment of endothelium-dependent responses of cerebral arterioles in chronic hypertension. Am J Physiol 1987;253:H1435-40.
37. Yang ST, Mayhan WG, Faraci FM, Heistad DD. Endothelium-dependent responses of cerebral blood vessels during chronic hypertension. Hypertension 1991;17:612-8.
38. Shibota M, Nagaoka A, Shino A, Fujita T. Renin-angiotensin system in stroke-prone spontaneously hypertensive rats. Am J Physiol 1979;236:H409-16.
39. Nagaoka A, Shino A, Shibota M. Implication of renal perfusion pressure in stroke of spontaneously hypertensive rats. Am J Physiol 1980;238:H317-24.
40. Wilde DW, Furspan PB, Szocik JF. Calcium current in smooth muscle cells from normotensive and genetically hypertensive rats. Hypertension 1994;24:739-46.